Holen Sie sich die Stockscreener-App
20.88
0.85%
-0.18
Handel nachbörslich:
20.90
0.02
+0.10%
Schlusskurs vom Vortag:
$21.06
Offen:
$21.04
24-Stunden-Volumen:
84,016
Relative Volume:
0.47
Marktkapitalisierung:
$863.51M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
-1.14%
1M Leistung:
+10.42%
6M Leistung:
+0.14%
1J Leistung:
+11.48%
1-Tages-Spanne:
$20.81
$21.10
1-Wochen-Bereich:
$20.53
$21.38
52-Wochen-Spanne:
$18.42
$22.60
Abrdn Healthcare Opportunities Fund Stock (THQ) Company Profile
Firmenname
Abrdn Healthcare Opportunities Fund
Sektor
Branche
Telefon
-
Adresse
-
Vergleichen Sie THQ mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THQ
Abrdn Healthcare Opportunities Fund
|
20.88 | 863.51M | 0 | 0 | 0 | 0.00 |
|
DNP
Dnp Select Income Fund Inc
|
9.43 | 3.49B | 0 | 0 | 0 | 0.00 |
|
UTG
Reaves Utility Income Fund
|
33.46 | 2.94B | 0 | 0 | 0 | 0.00 |
|
ETY
Eaton Vance Tax Managed Diversified Equity Income Fund
|
15.48 | 2.44B | 0 | 0 | 0 | 0.00 |
|
UTF
Cohen Steers Infrastructure Fund Inc
|
24.39 | 2.35B | 0 | 0 | 0 | 0.00 |
|
ADX
Adams Diversified Equity Fund
|
20.65 | 2.31B | 0 | 0 | 0 | 0.00 |
Abrdn Healthcare Opportunities Fund Aktie (THQ) Neueste Nachrichten
THQ: Improved Performance But Trades At Fair Value - Seeking Alpha
Abrdn U.S. Closed-End Funds Announce Distribution Payment Details - WICZ
Infrastructure & Healthcare Fund Alert: Two Top CEFs Announce Generous Yields Over 10% - StockTitan
Two Areas of Opportunity for 2025 - Stock Investor
Fierce Biotech Fundraising Tracker '25: Atalanta snares $97M series B; Helicore raises $65M - Fierce Biotech
abrdn U.S. Closed-End Funds Announce Distribution Payment Details - ACCESS Newswire
2 Big Dividends To Buy And Hold Forever - Seeking Alpha
A Gift Of Yields Up To 11% - Seeking Alpha
French PE fund Jeito Capital invests in global biopharma growth with Aviceda and XyloCor Therapeutics - EU-Startups
Aviceda Therapeutics Raises Upsized $207.5 Million in Series C Financing Round to Advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - BioSpace
Jeito Capital announces significant participation in upsized $207.5 million Series C financing in Aviceda Therapeutics to advance Lead Program AVD-104 for Geographic Atrophy into Pivotal Trials - The Manila Times
THQ: Healthcare Weakness Presents Opportunity, But Potentially Better Alternatives Exist - Seeking Alpha
My #1 Income Strategy For 2025 (Safety, 14% Dividends On The Table) - Contrarian Outlook
abrdn Private Equity Opportunities (LON:APEO) Trading Down 1% – Here’s What Happened - Defense World
THQ: Tempest On The Horizon (NYSE:THQ) - Seeking Alpha
ACPabrdn Income Credit Strategies Fund Latest Stock News & Market Updates - StockTitan
THW: Revisiting The 11.8% Healthcare Yielder As Thesis Plays Out (NYSE:THW) - Seeking Alpha
Health and Safety - University of Aberdeen
The Wellcome Trust Institutional Strategic Support Fund (ISSF @ Aberdeen) - University of Aberdeen
THQ (Tekla Healthcare Opportunities Fund) Change In Prepaid Assets : $-0.1 Mil (TTM As of Mar. 2024) - GuruFocus.com
Nuvig Therapeutics Announces $161 Million Series B Financing and Progression to Phase 2 Development with Novel, Second-Generation Immunomodulator - Business Wire
THQ (Tekla Healthcare Opportunities Fund) Enterprise Value : $1,081.0 Mil (As of Dec. 05, 2024) - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Earnings Power Va - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Cash Flow from Fi - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Purchase Of Busin - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Purchase Of Inves - GuruFocus.com
THQ (Tekla Healthcare Opportunities Fund) Sale Of Business : $0.0 Mil (TTM As of Mar. 2024) - GuruFocus.com
Nature and health — a perfect partnership - Scottish Natural Heritage
abrdn Funds ASGI, THQ Declare Distributions; ASGI Yields 8.46% 5-Year Return - StockTitan
THW: Valuation Is Attractive Once More (Rating Upgrade) - Seeking Alpha
THQ (Tekla Healthcare Opportunities Fund) Growth Rank : 0 (As of Nov. 26, 2024) - GuruFocus.com
HQH: Declines Bring Potential Opportunity (NYSE:HQH) - Seeking Alpha
Polar Capital operating profits climb 21% despite lack of performance fees - Investment Week
abrdn Healthcare Opportunities Fund declares $0.18 dividend - MSN
Brazil’s Patria could exceed target on first post-Abrdn secondaries fund - Secondaries Investor
Saba indicates UK buying opportunity with renewed Abrdn stake - Citywire Investment Trust Insider
Need $450 a Month in Passive Income? Invest $5K Each in These 9 Funds - 24/7 Wall St.
Asia ex Japan equities: abrdn versus Schroder - Fund Selector Asia
QuotedData’s Investment Companies Quarterly Review – Third quarter of 2024 - QuotedData
abrdn Total Dynamic Dividend Fund (AOD) Announces Update on Proposed A... - Moscow-Pullman Daily News
I Am Banking On The Silver Tsunami With Big Dividends - Seeking Alpha
THQ: Discount Narrows Further, But Healthcare Remains Attractive (NYSE:THQ) - Seeking Alpha
PortfolioPlus S&P Small Cap ETF (NYSEARCA:PPSC) Trading Up 1.3% – Time to Buy? - Defense World
Finanzdaten der Abrdn Healthcare Opportunities Fund-Aktie (THQ)
Es liegen keine Finanzdaten für Abrdn Healthcare Opportunities Fund (THQ) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
0.86%
0.28%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):